Questions? 10 seconds to sign up
Join the platform
Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
August 15, 2025
Approximately 5 minutes
Medicines: Register to Manufacture, Import or Distribute Active Substances in the UK
Medicines: Register to Manufacture, Import or Distribute Active Substances in the UK
Overview
Active substances (often called active pharmaceutical ingredients – APIs) are the components that give medicinal products their therapeutic effect. If you manufacture, import or distribute active substances and your activities are based in the UK, you must register with the Medicines and Healthcare products Regulatory Agency (MHRA). You can complete this registration via the MHRA Process Licensing (PCL) Portal.
Source: Medicines: register to manufacture, import or distribute active substances - GOV.UK
You must also comply with good manufacturing and distribution practice (GMDP) when undertaking these activities.
Source: Medicines: register to manufacture, import or distribute active substances - GOV.UK
The Registration Process
- Submit an application via the MHRA PCL Portal for registration as a manufacturer, importer or distributor.
- New applications are normally processed within 60 working days, excluding time taken to request additional information.
- Variations that do not require an inspection take about 30 working days to process.
- If an inspection is required, the MHRA will arrange a site visit before issuing the registration document.
Source: Medicines: register to manufacture, import or distribute active substances - GOV.UK
Change Your Registration
You must notify the MHRA via the MHRA PCL Portal if the details in your original registration change (for example, changes to your site information or activities). Some changes may require a new inspection and fees.
Source: Medicines: register to manufacture, import or distribute active substances - GOV.UK
Annual Compliance Reports
Registered active substance manufacturers, importers and distributors must complete an annual compliance report. This report is due every year by 30 April and should be submitted via the MHRA PCL Portal.
Source: Medicines: register to manufacture, import or distribute active substances - GOV.UK
Terminate Your Registration
To terminate your registration, you should complete the Termination Form provided on the MHRA guidance page and email it to pcl@mhra.gov.uk. There is no fee for termination, but to avoid paying the next annual fee, the request must be made before 31 December of the preceding year.
Source: Medicines: register to manufacture, import or distribute active substances - GOV.UK
Fees and Payment
The fee payable for registration varies depending on the number of sites included in your application. Detailed fees are available in the MHRA fee schedule linked from the guidance page.
Source: Medicines: register to manufacture, import or distribute active substances - GOV.UK
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Clinical Trials That Include an In Vitro Diagnostic Device in the UK
Guidance on submitting an application for approval of a clinical trial that includes an in vitro diagnostic device.
Approximately 5 minutes
Clinical Trials for Medicines: Ending a Clinical Trial in the UK
Guidance on legal and regulatory **steps to formally end a clinical trial** in the UK, including notifying authorities, publishing results, and dealing with approval lapses.
Approximately 5 minutes
Clinical Trials: Non-Investigational Medicinal Products in the UK
Guidance on the definition, use, documentation, manufacture, labelling and safety reporting of **non-investigational medicinal products (NIMPs)** in clinical trials.